The efficacy of hydroxyurea in patients is monitored through regular blood tests to measure HbF levels, complete blood counts, and clinical assessments of symptoms. Healthcare providers also track the frequency of painful episodes, hospitalizations, and other complications associated with sickle cell disease to evaluate the effectiveness of the treatment.
